Simply Good Foods (NASDAQ: SMPL) owns Quest, Atkins, and OWYN. Quest is growing 12% a year and might be one of the best protein bar brands in America. The stock has lost more than half its value since last April. The founder just walked back through the front door as CEO. And a Republican congressman quietly bought $15,000–$50,000 worth of shares last week.
Either this is a value trap with a broken brand dragging down the whole portfolio — or it’s a setup where one bad actor (Atkins) is obscuring real strength. Here’s what the numbers say.
Three Brands, One Problem
Simply Good Foods runs three brands. The difference between them could not be more stark:
- Quest: +12% retail consumption growth in Q1 FY2026. High-protein bars, chips, cookies. Sells well at Target, Walmart, Amazon. Has been winning shelf space for years.
- OWYN: +17.8% retail consumption in Q1 FY2026. Acquired June 2024 for around $280M. Plant-based protein shakes. Still accelerating.
- Atkins: Declining. Lost distribution. Got a $60.9M goodwill impairment in FY2025. Still dragging gross margins down.
The Atkins problem is real. The brand peaked somewhere around 2020 when low-carb diets were having a cultural moment. GLP-1 drugs (Ozempic, Wegovy) killed some of that demand — people who used to manage weight through Atkins bars now suppress appetite with a weekly injection. The company lost meaningful retail distribution in FY2026 and gave management’s own guidance: Atkins will be a headwind all year.
But here’s the thing: Quest and OWYN combined are growing enough that without Atkins, this business looks much better. The consolidation is happening in slow motion, and whoever’s willing to hold through the transition might get paid.
Q1 FY2026: The Numbers Behind the Story
For the 13 weeks ended November 29, 2025 (reported January 8, 2026):
- Net sales: $340.2M — down just 0.3% YoY, but that headline masks diverging brand trajectories
- Gross margin: 32.3% — down 590 basis points YoY, driven by record cocoa prices and new tariff-related input costs
- Adjusted EBITDA: $55.6M — down 20.6% YoY
- Adjusted diluted EPS: $0.39 — beat the consensus estimate by $0.03
- Net income: $25.3M — down 33.7% YoY (GAAP hit from margin compression)
- Cash on hand: $194.1M with $400M term loan outstanding; net debt/adjusted EBITDA at 0.8x
The gross margin hit is the main concern here. A 590 basis point single-quarter decline is not small. Management attributed it to cocoa inflation (Quest bars and cookies use a lot of chocolate) and tariff-related cost increases. They’re guiding for 100–150 bps of gross margin decline for the full FY2026 — which implies Q2 and Q3 pressures persist before a back-half recovery.
Management explicitly flagged Q2 as the weak quarter, with net sales expected to fall 3.5–4.5% YoY. They reaffirmed full-year guidance anyway: net sales -2% to +2%, adjusted EBITDA -4% to +1%.
The stock jumped 6.6% on earnings day. Investors were relieved the business didn’t fall off a cliff.
Joe Scalzo Is Back — and That Matters
On January 20, 2026, Simply Good Foods announced that Joe Scalzo was returning as President and CEO, effective immediately. He replaced Geoff Tanner, who had held the role since July 2023.
Scalzo isn’t an outside hire brought in to stabilize things. He built this company. He served as CEO for six years, from the company’s founding through July 2023, and is widely credited with turning Quest into a $1B+ brand and orchestrating the OWYN acquisition thesis. He stayed on as Executive Vice Chairman after stepping down — he never really left the building.
Founder returns are a mixed signal in public markets. Sometimes it’s a rescue mission for a struggling company (see: Starbucks, Howard Schultz). Sometimes it genuinely unlocks execution because the person who built the culture comes back to fix what drifted. With SMPL, the Atkins impairment happened under Tanner’s watch. The OWYN integration — largely clean — happened under Tanner’s watch too. The new question is whether Scalzo can accelerate the Quest/OWYN growth story while managing the Atkins decline without letting it contaminate the whole portfolio.
His compensation structure was reportedly restructured with a performance-based component tied to stock price recovery. That detail matters: he’s not getting paid to coast.
The $200M Buyback and Why Congress Is Watching
The board approved a $200M increase to the share repurchase program in Q1. The company had already repurchased 7.4 million shares for $146.6M year-to-date by the time Q1 results were reported — at an average price around $19.80. With the stock sitting near its 52-week low, every buyback dollar buys more shares than it would have six months ago when the stock was in the mid-$30s.
The company still has significant capacity remaining under its repurchase authorization. With net debt/EBITDA at 0.8x — conservative by consumer packaged goods standards — there’s room to continue buybacks without stressing the balance sheet.
And then there’s the congressional angle. Representative Tim Moore (R-NC) disclosed on February 20, 2026 that he purchased between $15,001 and $50,000 of SMPL stock on February 11. Congressional stock trades are legally required disclosures, not investment advice — members of Congress buy and sell stocks for many reasons. But when a politician spends their own money on a beaten-down consumer brand at a multi-year low, it gets attention. Moore isn’t on any financial services committee with obvious information advantages on food stocks, which makes this read more like a value bet than anything else.
Insider buying at the corporate level is also net positive. According to Simply Wall St, SMPL insiders have bought more shares than they’ve sold over the past three months. That’s against a backdrop where many consumer companies are seeing insiders reduce exposure.
Bull Case: Quest Is the Story, Atkins Is a Distraction
The bull case for SMPL is essentially this: you’re paying 19x trailing earnings for a portfolio where the good brands are growing double digits and the bad brand is in managed decline.
Quest at 12% consumption growth is not a slow-moving incumbent. Quest chips went from novelty snack to mainstream grocery staple. Quest protein donuts launched in October 2025. The innovation pipeline is working. OWYN at 17.8% growth is even more interesting — plant-based protein isn’t dying, it just lost the early hype premium, and a 17% grower in that space is underappreciated.
The secular trend supporting all three brands — consumer interest in high protein, low sugar, low carb products — is real and probably durable. Ironically, the GLP-1 drug users who might have cut back on Atkins are still watching macros. Some of them are buying Quest protein bars because they’re trying to hit 100g of protein a day while eating fewer calories. GLP-1 users are obsessed with protein intake to preserve muscle mass. That’s the customer Quest wants.
Eight analysts cover SMPL. The average 12-month price target is $33.63. Against a current price around $20, that’s roughly 68% implied upside on the consensus. That’s not a rounding error — that’s a market where the majority of professional coverage thinks the stock is significantly mispriced.
For context on valuation: SMPL at 19x trailing earnings against 12% consumption growth in its lead brand looks cheap relative to other branded consumer companies. Hershey trades at 23x despite essentially no growth. Mondelez is at 18x. Simply Good Foods owns a brand that’s outgrowing both of them and trades at a discount.
Bear Case: Margin Compression Is Structural
The bear case starts with the gross margin chart. Going from 38%+ gross margins to 32.3% in one quarter is not a short-term blip. Cocoa prices are near record highs and cocoa-heavy products (Quest bars, Quest cookies) make up a substantial portion of revenue. Tariffs on imported inputs add another layer. Management is guiding for ongoing gross margin pressure through FY2026, which means EBITDA could stay depressed even if revenue stabilizes.
Atkins isn’t going away quietly. The company still sells hundreds of millions of dollars of Atkins product and has to market and distribute it. Every dollar spent maintaining Atkins distribution is a dollar that could be accelerating Quest or OWYN. And the impairment signal is worth taking seriously: when a company writes down the goodwill on a brand by $60.9M, they’re acknowledging the acquisition value isn’t there anymore. Atkins was acquired for roughly $800M in 2017. That impairment opens the door to more.
The balance sheet isn’t dangerous but it’s not pristine. A $400M term loan against $194M in cash gives you net debt of ~$206M. With interest rates still elevated, interest expense guidance for FY2026 is $19–21M. That’s manageable but it’s real cash leaving the business.
And the Q2 warning is concrete: net sales down 3.5–4.5% YoY, adjusted EBITDA probably at or near the weakest quarter of the year. Q2 results will be reported roughly in April 2026. If those miss, the stock sees another leg down. The multi-year low ($18.45) is close, and a bad Q2 print could break through it.
The Verdict
SMPL at $20 is a reasonable entry for patient investors who believe Quest is a durable brand and Atkins is a solvable problem. The founder CEO returning, a $200M buyback, net insider buying, and an 8-analyst consensus target of $33.63 are all pointing the same direction. The 68% gap between stock price and analyst consensus is too wide to ignore.
But this isn’t a sprint. The next catalyst is Q2 earnings, and management pre-warned it will be the worst quarter of the year. Anyone buying here should be prepared to sit through a potentially ugly spring. The margin compression story doesn’t resolve until Q4 at the earliest, assuming cocoa prices cooperate.
The setup: buy at $18–20 with a 12–18 month thesis. Watch gross margins in Q2. If they stabilize at 33%+ heading into Q3, the recovery thesis is intact. If they fall below 31%, it means the cocoa and tariff headwinds are worse than guided, and the position size should shrink.
The 52-week low is $18.45. The founder is back. Congressional money is coming in. And the market is pricing this thing like Atkins is the whole company — when Quest is growing faster than most snack brands in America.
For more analysis of consumer and health brands that fell despite solid underlying business, see our takes on Hims & Hers (HIMS) and Lemonade (LMND). For a broader look at small cap beats this earnings season, see our coverage of Amplitude (AMPL).
This is not financial advice. Do your own research. I hold no position in SMPL.